Potential modification of the UKPDS risk engine and evaluation of macrovascular event rates in controlled clinical trials

por Yang, Fred, Ye, June, Pomerantz, Kenneth, Stewart, Murray
Publicado 2013

Type 2 diabetes mellitus development programs in the new regulatory environment with cardiovascular safety requirements

por Yang, Fred, Stewart, Murray, Ye, June, DeMets, David
Publicado 2015

Determining MRI Inflammation Targets When Considering a Rheumatoid Arthritis Treat-to-Target Strategy: Results of a Randomized, Placebo-Controlled Trial

por Ahmad, Harris A., Baker, Joshua F., Østergaard, Mikkel, Ye, June, Emery, Paul, Conaghan, Philip G.
Publicado 2019

Efficacy of Abatacept and Adalimumab in Patients with Early Rheumatoid Arthritis With Multiple Poor Prognostic Factors: Post Hoc Analysis of a Randomized Controlled Clinical Trial...

por Fleischmann, Roy, Weinblatt, Michael, Ahmad, Harris, Maldonado, Michael A., Alemao, Evo, Ye, June, Schiff, Michael
Publicado 2019

Baseline Objective Inflammation by Magnetic Resonance Imaging as a Predictor of Therapeutic Benefit in Early Rheumatoid Arthritis With Poor Prognosis

por Ahmad, Harris A., Baker, Joshua F., Østergaard, Mikkel, Emery, Paul, Durez, Patrick, Ye, June, Banerjee, Subhashis, Conaghan, Philip G.
Publicado 2020

Body mass index and clinical response to intravenous or subcutaneous abatacept in patients with rheumatoid arthritis

por D’Agostino, Maria-Antonietta, Alten, Rieke, Mysler, Eduardo, Le Bars, Manuela, Ye, June, Murthy, Bindu, Heitzmann, Julia, Vadanici, Radu, Ferraccioli, Gianfranco
Publicado 2017

Identification of biomarkers of response to abatacept in patients with SLE using deconvolution of whole blood transcriptomic data from a phase IIb clinical trial

por Bandyopadhyay, Somnath, Connolly, Sean E, Jabado, Omar, Ye, June, Kelly, Sheila, Maldonado, Michael A, Westhovens, Rene, Nash, Peter, Merrill, Joan T, Townsend, Robert M
Publicado 2017

Conversion to seronegative status after abatacept treatment in patients with early and poor prognostic rheumatoid arthritis is associated with better radiographic outcomes and sust...

por Jansen, Diahann T S L, Emery, Paul, Smolen, Josef S, Westhovens, Rene, Le Bars, Manuela, Connolly, Sean E, Ye, June, Toes, René E M, Huizinga, Tom W J
Publicado 2018

Remogliflozin Etabonate, a Selective Inhibitor of the Sodium-Glucose Transporter 2, Improves Serum Glucose Profiles in Type 1 Diabetes

por Mudaliar, Sunder, Armstrong, Debra A., Mavian, Annie A., O’Connor-Semmes, Robin, Mydlow, Patricia K., Ye, June, Hussey, Elizabeth K., Nunez, Derek J., Henry, Robert R., Dobbins, Robert L.
Publicado 2012

Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial

por Thaçi, Diamant, Strober, Bruce, Gordon, Kenneth B., Foley, Peter, Gooderham, Melinda, Morita, Akimichi, Papp, Kim A., Puig, Lluís, Menter, M. Alan, Colombo, Matthew J., Elbez, Yedid, Kisa, Renata M., Ye, June, Napoli, Andrew A., Wei, Lan, Banerjee, Subhashis, Merola, Joseph F., Gottlieb, Alice B.
Publicado 2022